Skip to main content

Month: March 2024

Mortgage Rates Increase, Nearing Seven Percent

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 03/21/2024MCLEAN, Va., March 21, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.87 percent. “After decreasing for a couple of weeks, mortgage rates are once again on the upswing,” said Sam Khater, Freddie Mac’s Chief Economist. “As the spring homebuying season gets underway, existing home inventory has increased slightly and new home construction has picked up. Despite elevated rates, homebuilders are displaying renewed confidence in the housing market, focusing on the fact that there is a good amount of pent-up demand, an ongoing supply shortage and expectations that the Federal Reserve will cut rates later in the...

Continue reading

Annual General Meeting of Jyske Bank A/S on 21 March 2024

At the Annual General Meeting, the annual report was presented and the financial statements for 2023 were adopted. The motions proposed by the Supervisory Board, cf. items c (remuneration report) and d (remuneration to the Shareholders’ Representatives and the Supervisory Board) were both adopted. The Supervisory Board’s motion to the effect that the Bank be authorised to acquire own shares (item e of the agenda) was adopted. The motions proposed by the Supervisory Board, cf. items f.1-f.5 of the agenda (remuneration policy and motions of amendments to the Articles of Association) were all adopted.  As the members in general meeting with a right to vote represented less than 90% of the share capital, an extraordinary general meeting will be called for the purpose of final adoption of the motions proposed under items f.2-f.5 as these...

Continue reading

Annual general meeting of Danske Bank 2024

Company announcement no 12 2024  Danske Bank A/SHolmens Kanal 2 – 12DK – 1092 København KTel. +45 45 14 00 00 21 March 2024Annual general meeting of Danske Bank 2024 At the annual general meeting of Danske Bank on Thursday, 21 March 2024, the general meetingadopted the Annual Report 2023 and the proposal for allocation of profit according to the adopted Annual Report 2023, approved the Board of Directors’ proposed Remuneration Report 2023 by advisory vote, adopted the Board of Directors’ proposal for approval of the Remuneration Policy 2024, re-elected Martin Blessing, Lars-Erik Brenøe, Jacob Dahl, Raija-Leena Hankonen-Nybom, Allan Polack and Helle Valentin to the Board of Directors. Martin Nørkjær Larsen and Lieve Mostrey were elected as new members of the Board of Directors, re-appointed Deloitte Statsautoriseret Revisionspartnerselskab...

Continue reading

Else Nutrition Schedules 2023 Fiscal Year Business Update Conference Call

VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today announced that it plans to host a business update conference call at 10:30 a.m. Eastern Time on April 1, 2024 to discuss the Company’s financial results for the 2023 fiscal year ended December 31, 2023, as well as the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1661271&tp_key=87e7860827 or on the Investor Relations section of the Company’s website at https://investors.elsenutrition.com/. A webcast replay will be...

Continue reading

TEN, Ltd. Announces Date of Fourth Quarter and Year End 2023 Results, Conference Call and Webcast

ATHENS, Greece, March 21, 2024 (GLOBE NEWSWIRE) — TEN, Ltd. (“TEN” or the “Company”) (NYSE: TNP) a leading diversified crude, product and LNG tanker operator, today announced that the Company will report earnings for the fourth quarter and year ended on December 31, 2023, prior to the open of the market in New York on Wednesday, March 27, 2024. That same day, at 12:00 p.m. Eastern Time, TEN will host a conference call to review the results as well as the management’s outlook for the business. The call, which will be hosted by TEN’s senior management, may contain information beyond that which is included in the earnings press release. Conference Call Details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877-405-1226 (US Toll-Free Dial In) or +1 201-689-7823 (US and...

Continue reading

Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities

Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorisation for Awiqli® (the brand name for once-weekly basal insulin icodec) for treatment of diabetes in adults. The positive CHMP opinion is based on results from the ONWARDS phase 3a clinical trial programme. Once-weekly basal insulin icodec achieved superior blood sugar reduction1 (measured by a change in HbA1c) and superior Time in Range2 (time spent within recommended blood sugar range), compared with daily basal insulin in people with type 2 diabetes. In people with type 2 diabetes who have not previously been treated with insulin, overall observed rates of clinically significant or severe hypoglycaemia3 were below one...

Continue reading

Dogfish Head Craft Brewery to Launch Sippin’ & Flippin’ Giveaway, Winner to Receive All-Expenses Paid Trip to a Concert of Their Choice

Sippin’ & Flippin’ to kick-off Dogfish Head’s month-long music celebration, which includes a partnership with Record Store Day, a host of sponsored concerts and events, and more.Dogfish Head’s Sippin’ & Flippin’ Concert GiveawayThroughout the month of April, in select independently owned record stores from coast-to-coast, Dogfish Head will hide commemorative, metallic-gold records among the shops’ stacks of vinyl. Lucky folks that stumble upon a golden record will not only win a swag bag full of goodies, but they will be entered for the chance to win the contest’s grand-prize trip – an all-expenses paid trip for two to a concert of their choosing.MILTON, Del., March 21, 2024 (GLOBE NEWSWIRE) — Self-proclaimed “beer geeks with a music problem,” Dogfish Head Craft Brewery announces Sippin’...

Continue reading

SPZI: JP 3E Holdings, Inc. Retains Accell Audit & Compliance, PA to Audit the Financial Statements

JP 3E Holdings, Inc., formerly Spooz Inc., will become a Fully Reporting Company, Retaining Accell Audit & Compliance, PA in pursuit of Uplisting CLEARWATER, Fla., March 21, 2024 (GLOBE NEWSWIRE) — JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI), retains Accell Audit & Compliance, PA to audit the company’s financials to become an SEC Fully Reporting company. This is the first step toward achieving its goal of uplisting first to the OTCQB. Accell is registered with the Public Company Accounting Oversight Board (PCAOB) and provides audit services to several hundred clients, from high-tech start-up companies to Fortune 500. Its current client portfolio includes numerous public and private companies across many industries, with operations on at least five continents.http://www.theaccellgroup.com/ Accell is a licensed...

Continue reading

Savaria Declares Monthly Dividend (Record Date Correction)

LAVAL, Quebec, March 21, 2024 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, declared today a dividend of 4.33 cents ($0.0433) per common share, in accordance with its monthly dividend policy, payable on April 10, 2024, to shareholders of record of the Corporation at the close of business on March 28, 2024. This is an eligible dividend within the meaning of the Income Tax Act. About Savaria Corporation Savaria Corporation (savaria.com) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts...

Continue reading

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

PALO ALTO, Calif., March 21, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the out-of-pocket costs for its product portfolio for commercially insured patients is expected to be capped at $25 monthly, with certain eligible patients paying as low as $0. This applies to the Company’s postherpetic neuralgia pain product, ZTlido®, migraine product, ELYXYB®, and gout flare prophylaxis product, Gloperba®, which is expected to launch in the first half of 2024. Scilex has made significant investments to improve patient affordability and access to its products and continues to build on the Company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.